This reduced biological activity of glycated insulin may be caused due to its decreased affinity for the insulin receptor, poor insulin signaling, or it may function as a ligand for the receptor for advanced glycation end products, activating oxidative stress and pro-inflammatory pathways that result in insulin resistance [42]. The gene discussed is INS; the disease is Insulin resistance.